Alex Goldberg

NASDAQ Gainers Watch List: Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/24/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT).

Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) operates as the bank holding company for Susquehanna Bank that provides a range of retail and commercial banking, and financial products and services in the mid-Atlantic region closed up in its previous session (+1.41%) on 1,651,670 shares traded. Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) is currently up (+25.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Susquehanna Bancshares, Inc. (NASDAQ:SUSQ)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) a biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases closed up in its previous session (+2.15%) on 1,788,598 shares traded after Sarepta was upgraded to Neutral from Underweight at Piper Jaffray. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is currently up (+72.19%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com